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Abstract
Background: Non-participants can have a considerable influence on the external validity of a
study. Therefore, we assessed the socio-demographic, health-related, and lifestyle behavioral
differences between participants and non-participants in a comprehensive CVD lifestyle
intervention trial, and explored the motives and barriers underlying the decision to participate or
not.
Methods: We collected data on participants (n = 50) and non-participants (n = 50) who were
eligible for inclusion in a comprehensive CVD lifestyle interventional trial. Questionnaires and a
hospital patient records database were used to assess socio-demographic, health-related and
lifestyle behavioral variables. Univariate and multivariate logistic regression was used to describe
the relationship between explanatory variables and study participation. Furthermore, motives and
barriers that underlie study participation were investigated by means of questionnaires.
Results: Participants were younger, single, had a higher level of education and were employed. No
statistically significant differences were found in health measures and behavioral variables. The
motives for participation that were most frequently reported were: the perception of being
unhealthy and willingness to change their lifestyle. The main barriers reported by non-participants
were financial arguments and time investment.
Conclusion: The differences between participants and non-participants in a lifestyle intervention
trial are in mainly demographic factors. The participants consent in order to alter their lifestyle,
and/or because they want to improve their health. To minimize non-participation, it is
recommended that access to a lifestyle intervention program should be easy and cause no financial
restraints.
Trial registration: ISRCTN69776211.
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Background
The challenge in the recruitment of patients for clinical tri-
als is to minimize non-participation among the target
population. Non-participants can have a considerable
influence on the external validity of a study [1,2], and
make it difficult to meet the goals of recruitment within a
specified time-limit and budget [3]. Enrollment rates in
clinical trials vary, and obtaining informed consent from
patients may sometimes be difficult [4]. Reasons for non-
participation that have been reported by patients with
heart failure are the perception of being too unwell, lack
of transport, being too old, or too busy [5]. Living too far
away from the study site or indifference towards the study
[6], as well as concerns about inconvenience/annoyance
and the possibility of being randomized to the control
group have also been reported as barriers to participation
[7]. Motivations for participation seem to be altruistic per-
ceptions and perceived benefits [7]. Earlier investigations
of unwanted selective inclusion in trials involving cardio-
vascular disease (CVD) patients show that smokers [7],
older patients [5,7,8], women [5,7], and patients who live
further away from the study site [6] are sub-groups that are
less likely to consent.
The mechanisms underlying participation and the threat
for the external validity of the study results have scarcely
been investigated in rehabilitation or secondary preven-
tion programs for CVD patients. A non-participation sur-
vey among CVD patients who were offered an intensive
rehabilitation program demonstrated that the participants
were younger, still working and had a higher level of edu-
cation than the non-participants [9]. At present, the
emphasis of secondary prevention in CVD patients lies
increasingly on multifactorial risk reduction through life-
style intervention therapy [10,11], but the non-participa-
tion of CVD patients has not yet been evaluated in lifestyle
intervention trials.
At the VU University in Amsterdam we are conducting the
ALANT study (Activity, Lifestyle And Nutritional Therapy-
study) on the cost-effectiveness of a multifactorial com-
prehensive lifestyle intervention program for CVD
patients. The program has already been described in more
detail in an intervention study with no control group [12].
Figure 1 is a flow chart of patient recruitment for the
ALANT study and the present survey. A total of 15,343
patients were screened for the ALANT study, 877 of whom
Flow chart of patient recruitment in the ALANT Study and in the non-participant survey Figure 1
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were assessed by the medical specialists as eligible for par-
ticipation in the study. The other patients did not meet the
inclusion criteria, or did not show up for their appoint-
ment, or were not assessed by the medical specialists. A
total of 729 (83%) of the 877 eligible patients decided not
to participate. We therefore evaluated the socio-demo-
graphic, health-related, and lifestyle behavioral differ-
ences between participants and non-participants in this
trial. Motivational aspects involved in trial participation
and barriers for participation were also evaluated in order
to enable us to make recommendations for successful
patient recruitment in the future.
Methods
Participants
Eligible patients from the vascular and cardiology outpa-
tient departments of the Academic Hospital of the VU
University were invited to participate in the ALANT study
by their medical specialist during consulting-hours. In
addition, potentially eligible patients were identified in
the databases of the departments of cardiology and vascu-
lar surgery. Members of the research team contacted these
patients by telephone shortly after having sent them a let-
ter of invitation by mail. Consecutive participants and
non-participants in the ALANT study were then invited to
take part in our survey, the protocol of which was
reviewed and approved by the Medical Ethics Committee
of the VU Medical Center.
Eligible for participation in the ALANT study were
patients with stable CVD, between 18 and 75 years of age,
with at least one of the following risk factors: smoking,
diabetes, hypertension, dyslipidemia, hypercholestero-
lemia, overweight/obesitas or not meeting the recom-
mended level of regular physical activity. Patients who
were unable to climb a flight of stairs or to communicate
adequately in the Dutch language were excluded from
participation, as well as those who had unstable CVD or
diabetes with a glycated hemoglobin (HbA1c) above
10.0%. Finally, their comorbidity had to be stable, and
there should be no contra-indication for them to engage
in physical exercise, as assessed by the referring physician.
CVD was defined as coronary heart disease, a history of
transient ischemic attack, cerebrovascular accident, or
signs of peripheral vascular disease. The Body Mass Index
(BMI) was calculated as weight (in kg)/height (in m)2,
and was used to identify patients who were overweight
(BMI >25) or obese (BMI >30). Hypertension was defined
as the use of antihypertensive medication, or systolic
blood pressure above 140-mmHg and/or diastolic blood
pressure above 90 mmHg. The recommended level of
physical activity was defined as moderate intensive exer-
cise for at least half an hour, five times a week (i.e. brisk
walking, cycling or other forms of brisk exercise).
Patients had to be referred by a physician in order to
obtain compensation from their health insurance com-
pany, but this did not include a financial contribution of
€ 150 for patients allocated to the lifestyle program.
The inclusion of participants and non-participants in this
survey was stopped when 50 questionnaires had been
filled in and returned by each group. This cut-off point
was chosen in order to achieve a representative, yet feasi-
ble sample in both groups.
Measurements
Data were collected from questionnaires and the patient
record database of the VU Medical Center. Successive non-
participants in the ALANT study were asked by telephone
to complete and return a questionnaire, and two gift
vouchers were raffled among the non-participants who
did so. Patients who did not return the questionnaire after
two weeks received another questionnaire by mail and a
booster telephone call shortly afterwards. Successive par-
ticipants in the ALANT study were asked to fill in the same
questionnaire during their first measurement visit.
The following socio-demographic, health-related and
behavioral variables were studied:
Socio-demographic variables
Gender, age, marital status (married/living together, yes/
no), level of educational (none or primary education, sec-
ondary education, higher education), job status (working,
unemployed, retired), distance from the patient's home to
the hospital, and ethnicity. The term ethnic minority was
used when at least one of the patient's parents had not
been born in the Netherlands [13].
Health-related variables
- Perceived general health
Perceived general health was assessed with one question
derived from the SF-36 ('how is your health in general?')
[14] and the EuroQol [15]. The EuroQol questionnaire
assesses the general health status in 5 dimensions: mobil-
ity, self-care, usual activities, pain/discomfort, and anxi-
ety/depression. Based on the model developed by Lamers
et al., the total score was expressed in utilities (0–1)
according to values for the general population of the
Netherlands and subsequent statistical modeling [16].
- Clinical variables
BMI was calculated on the basis of self-reported weight
and height. The variables hypertension and co-morbidity dia-
betes were retrieved from the patient's most recent medical
records, dating from the previous two years.BMC Medical Research Methodology 2008, 8:17 http://www.biomedcentral.com/1471-2288/8/17
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Behavioral variables
- Lifestyle behaviors
The questionnaire contained questions about current
smoking, pack years (average number packs of 20 ciga-
rettes per day smoked, multiplied by the number of years
as a smoker), and meeting the recommended levels of
physical activity (yes/no).
- Stages of behavioral change
Stages of behavioral change in physical activity were deter-
mined according to the trans theoretical model TTM [17].
The TTM identifies specific stages that individuals go
through when trying to change their behavior. The stages
of change include pre-contemplation (not thinking about
making changes), contemplation (thinking about making
changes, but not immediately), preparation (planning to
make changes within the next 30 days, and may already be
making small changes), action (initiated the changes in
the past 6 months), and maintenance (maintained the
changes for more than 6 months) [17].
Motives and barriers for participation
A four-item Likert scale was used to assess the role of var-
ious determinants that were presumed by the investiga-
tors to influence the decision to participate or not (time
investment, costs, interest in the study, changing daily
routine, poor health status, health 'too good', and dis-
tance to study site/transport). The questionnaire also con-
tained one open question: 'Why did you decide (not) to
participate in the study?' Two members of the research
team independently categorized the answers to this open
question; disagreements were resolved after discussion.
Statistical analysis
Socio-demographic and clinical group means were com-
pared, using Chi-square tests for categorical data and
independent T-tests for continuous data. Univariate logis-
tic regression was used to describe the relationship
between explanatory variables and study participation
(yes/no). The multivariate model was then constructed
with variables that had a univariate P value of 0.1 or less.
The step-forward procedure was followed by first putting
the variable with the lowest P value in the model, fol-
lowed by the next lowest, and so on. Variables with a P
value of less than 0.05 were retained in the model and the
other variables were omitted, unless they changed the
odds ratios (OR) of the independent variable or one of the
other variables by more than 10%. The level of signifi-
cance was set at P < 0.05, and the statistical analysis was
performed in SPSS, version 12.0.1 [18].
Results
All of the 65 non-participants who were contacted were
reached by phone, and they all agreed to complete a ques-
tionnaire, but 15 (23%) of the non-participants did not
return the questionnaire. All of the 50 participants who
had been invited agreed to participate in this survey and
completed the questionnaire.
Socio-demographic, health-related, and lifestyle 
behavioral differences
The characteristics of the non-participants and the partic-
ipants are presented in Table 1. There were statistical dif-
ferences with regard to age, level of education and
working situation. Marital status differed, but not statisti-
cally.
In the univariate logistic regression model, the variables
age, high level of education, still working, and being
retired showed a significant relationship with study partic-
ipation. These variables remained statistically significant
in the multivariate model (with the exception of being
retired), but being single also appeared to be highly signif-
icantly associated with study participation (Table 2).
Motives and barriers for participation
Willingness to change lifestyle, perceived poor health, and
interest in the study were reported as motives underlying
the decision to participate (Figure 2).
The main reason for participation derived from the
answers to the open question was: 'to improve my health'
(33 participants). Altruistic reasons for participation were
also mentioned, such as 'to help science' (8 participants).
Non-participants stated that time investment (17 partici-
pants) and financial arguments (16 participants) played
an important role in their decision to decline participa-
tion, and these were also the main reasons for non-partic-
ipation derived from the answers to the open question.
The greatest motivational differences between partici-
pants and non-participants were the willingness to change
and the level of interest in the study (Figure 2). Distance
to the hospital (where the measurements took place) was
also perceived as an important barrier for participation,
even though the mean distance as measured from the Zip
code of the patient's home address was similar for both
groups.
Discussion
The results of this study showed that the typical partici-
pant in a lifestyle intervention study for patients with sta-
ble cardiovascular disease was working, highly educated,
younger, single patient. Participants consented in order to
change their lifestyle, and/or because they wanted to
improve their health. The main reasons for non-participa-
tion were financial arguments and time investment. The
biggest motivational differences between participants and
non-participants were willingness to change their lifestyle
and interest in the study.BMC Medical Research Methodology 2008, 8:17 http://www.biomedcentral.com/1471-2288/8/17
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The observed demographical differences between partici-
pants and non-participants correspond with the findings
of an earlier study of non-participation in cardiac rehabil-
itation [9] and a Dutch cardiovascular risk survey [19].
The motives underlying the decision to participate are also
largely in line with the findings of an earlier study [7]. The
statement made by Gates et al. [20] can be confirmed by
our results: "Any cost (...) that patients perceive that they
may incur if they participate is likely to affect their deci-
sions about joining a trial".
Table 1: Characteristics of participants and non-participants in a multifactorial comprehensive lifestyle intervention trial for patients 
with CVD
Participants (n = 50) Non-participants (n = 50) 95% CI
Socio-demographic
Sex: male 35 (70.0%) 39 (78.0%) -0.25 to 0.09
Age (mean ± SD) 60.2 ± 8.9 64.3 ± 8.3 0.72 to 7.53*
Married or living together 29 (60.0%) 38 (76.0%) -0.33 to 0.03
Level of education
- Low 15 (31.3%) 24 (48.0%) -0.34 to 0.03
- Middle 15 (31.3%) 23 (46.0%) -0.32 to 0.04
- High 18 (37.5%) 3 (6.0%) 0.16 to 0.46*
Job status
- Retired 17 (35.4%) 30 (60.0%) -0.42 to -0.05*
- Working 17 (35.4%) 6 (12.0%) 0.07 to 0.39*
- Unemployed 14 (29.2%) 14 (28.0%) -0.16 to 0.19
Ethnic minority 10 (21.3%) 6 (12.5%) -0.07 to 0.24




- Good, very good or excellent 26 (54.2%) 28 (56.0%) -0.21 to 0.17
- Fair or poor 22 (45.8%) 22 (44.0%) -0.17 to 0.21
EuroQol (mean ± SD) 0.73 ± 0.3 0.80 ± 0.2 -0.04 to 0.18
Clinical
BMI (mean ± SD) 28.1 ± 5.4 27.0 ± 3.8 -2.99 to 0.73
Overweight (25<BMI < 30) 20 (40.0%) 23 (46.9%) -0.25 to 0.12
Obese (BMI > 30) 16 (32.0%) 8 (16.3%) -0.01 to 0.32
Co-morbidity diabetes 9 (18.0%) 10 (20.0%) -0.17 to 0.14
Hypertension 29 (58.0%) 30 (60.0%) -0.21 to 0.17
Behavioral variables
Lifestyle behaviors
Current smoker 17 (39.5%) 16 (32.0%) -0.12 to 0.26
Pack years (mean ± SD) 19.5 ± 19.3 14.7 ± 16.9 -12.32 to 2.73
Not meeting recommended levels of physical activity 33 (66.0%) 32 (65.3%) -0.27 to 0.33
Stages of behavioral change
Pre-contemplation 2 (4.2%) 8 (16.3%) -0.25 to 0.00
Contemplation 5 (10.4%) 5 (10.2%) -0.13 to 0.13
Preparation 8 (16.7%) 4 (8.2%) -0.05 to 0.22
Action 9 (18.8%) 12 (24.5%) -0.22 to 0.11
Maintenance 24 (50.0%) 20 (40.8%) -0.10 to 0.28
Statistical significance was assessed with Chi-square tests for categorical variables and t-tests for continuous variables.
CI: Confidence interval.
SD: Standard deviation.
BMI: Body Mass Index.
* P < 0.05BMC Medical Research Methodology 2008, 8:17 http://www.biomedcentral.com/1471-2288/8/17
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The perception of poor health was more often a reason to
participate than to decline; this is in contrast with previ-
ous reports in the literature [5,6]. Declining participation
because of poor health was, in fact, the patient's subjective
perception, because all the patients who were invited were
assessed by their cardiologist as being healthy enough to
participate. Although the distance to the hospital did not
differ significantly between the two groups, non-partici-
pants experienced this distance as a barrier. Travel time
and travel costs were not measured, but public transport
facilities within the study area are good.
While non-participants were more often not employed,
and probably had more free time, the time investment
required for participation was a frequently reported bar-
rier.
A few methodological issues need to be discussed. Firstly,
non-response under the non-participants was relatively
low (23%), so the absence of these pertinent non-
respondents is not likely to bias our profile of the typical
non-participant. Secondly, due to the relatively small
sample size, not all elevated ORs are significant.
Thirdly, BMI was calculated with self-reported weight and
height, which are known to be under-reported and over-
reported, respectively, in epidemiologic studies [21].
When we compared the self-reported BMI of the partici-
pants with their BMI measured by the physician, we found
a reported under-estimation with a mean difference of 0.7
kg/m2. However, this is not likely to bias the findings of
BMI group-comparisons, since BMI was self-reported in
both groups. Fourthly, we did not measure the enthusi-
asm and power of persuasion of the recruiters, which
might be closely related to stimulation of a patient's inter-
est [22]. However, we did measure lack of interest in the
study, and this appeared to be a reason for non-participa-
tion in seven cases. Fifthly, most studies do not require
payment from patients for the intervention. Therefore, the
results have to be interpreted with caution with regard to
comparison with other studies, and generalizability of the
results. Furthermore, because study participation implied
Table 2: The univariate and multivariate association of variables 
with participation in a multifactorial comprehensive lifestyle 
intervention trial for CVD patients
Univariate Odds Ratio (95% CI)
Age: one year older 0.95 (0.90–0.99)*
Level of education: high 9.40 (2.55–34.67)**




Married or living together with a partner 0.14 (0.04–0.48)**
Level of education: high 14.41 (3.27–63.56)**
(Still) working 8.88 (1.84–43.00)**
CI: Confidence Interval.
* P ≤ 0.05; **P ≤ 0.01
The role of determinants in the decision (not) to participate in the ALANT Study, reported on a four-item Likert scale by  (non-)participants in a CVD lifestyle intervention trial Figure 2
The role of determinants in the decision (not) to participate in the ALANT Study, reported on a four-item Lik-
ert scale by (non-)participants in a CVD lifestyle intervention trial.BMC Medical Research Methodology 2008, 8:17 http://www.biomedcentral.com/1471-2288/8/17
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possible costs, it is plausible that patients with a low
socio-economic status were less likely to participate.
Unfortunately, we were unable to evaluate the exact socio-
economic influences, because data on type of job or level
of income were not collected. Based on the data concern-
ing level of education there is reason to believe that socio-
economic class is of influence. This is reinforced by the
identified effect of the variable 'still working'.
Conclusion
The differences between participants and non-participants
are mainly based on demographic and motivational fac-
tors. Undoubtedly, the lifestyle intervention that was
offered does not meet the needs of certain sub-groups.
Further in-depth qualitative research could be beneficial
in identifying the best way to promote a change in lifestyle
in these groups. An individually tailored lifestyle program
might increase the willingness of patients to participate.
The most important barriers for participation are costs
and time investment. Although a lifestyle intervention is
often focused on people with a lower socio-economic sta-
tus, the financial burden of participation is likely to
increase non-participation, especially in this sub-group. It
is therefore recommended that participation should be
stimulated financially, or at least be free of charge.
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